Chemical Engineering Professor Shashi Murthy has received funding from the National Science Foundation to develop novel manufacturing technologies for cell-based cancer therapies. This project will be a collaborative effort with Cambridge, MA-based Neon Therapeutics which is developing neo-antigen-based therapeutic vaccines and cell-based therapies for cancer. Cell-based therapies represent the next major frontier in the treatment of cancer and their personalized nature presents unique challenges in manufacturing. This project brings together an interdisciplinary team of engineers and immunologists to design innovative automated bioreactors that can be optimized for biological function. This grant provides $300,000 in funding over a two year period to be shared equally by Northeastern and Neon Therapeutics.
WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Shashi K. Murthy, Ph.D., Professor of Chemical Engineering; Founding Director, Michael J. and Ann Sherman Center for Engineering Entrepreneurship Education, Chemical Engineering, Northeastern University, to its College of Fellows. Dr. Murthy was nominated, reviewed, and elected by peers and members of the College of Fellows For outstanding contributions to the science and technology of cell purification for therapeutic and analytical applications.